References concerning the statistics, counts or trends of those choosing various management options
List was last updated on
.-
- Breast Cancer Screening Utilization and Outcomes in Women with Neurofibromatosis Type 1.
- Yan K, Gao Y, Heller SL.
- Clin Breast Cancer. 2023 Feb 12:S1526-8209(23)00035-6. doi: 10.1016/j.clbc.2023.02.005. Epub ahead of print.
-
- Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers.
- Lee SS, Karpel HC, Oh C, Smith J, Pothuri B.
- Gynecol Oncol. 2023 Jan 30;170:234-240. doi: 10.1016/j.ygyno.2022.12.012. Epub ahead of print.
- PMID: 36724586
- PubMed abstract
- Source abstract
-
- Financial toxicity in BRCA1 and BRCA2 carriers.
- Proussaloglou EM, Rosenthal AE, Raker CA, Wilbur JS, Stuckey AR, Robison KM.
- Gynecol Oncol. 2023 Jan 24;170:160-166. doi: 10.1016/j.ygyno.2023.01.007. Epub ahead of print.
- PMID: 36701836
- PubMed abstract
- Source abstract
-
- Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan.
- Nomura H, Abe A, Fusegi A, Yoshimitsu T, Misaka S, Murakami A, Matsumoto T, Tsumura S, Kanno M, Aoki Y, Netsu S, Omi M, Tanigawa T, Okamoto S, Omatsu K, Yunokawa M, Kanao H, Habano E, Arakawa H, Kaneko K, Ueki A, Haruyama Y, Inari H, Ueno T.
- Sci Rep. 2023 Jan 19;13(1):1018. doi: 10.1038/s41598-023-28304-w.
- PMID: 36658289
- PubMed abstract
-
- Factors that influence the management recommendations breast surgeons provide to women with pathogenic variants in moderate penetrance breast cancer susceptibility genes.
- Vanderwal A, Lewis J, Basil J, Atzinger C, Widmeyer K.
- J Genet Couns. 2023 Jan 15. doi: 10.1002/jgc4.1674. Epub ahead of print.
- PMID: 36642783
- PubMed abstract
- Source abstract
-
- Variations in Practice and Geographic Disparities Between Dedicated Multidisciplinary Clinics for BRCA1/BRCA2 Mutation Carriers in Israel.
- Hermann N, Mor P, Kaidar-Person O, Bernstein-Molho R, Brodsky M, Madorsky Feldman D, Flugelman AA, Aboody Nevo H, Meshoulam Avital D, Sklair-Levy M, Friedman E, Allweis TM.
- Isr Med Assoc J. 2023 Jan;25(1):18-22.
- PMID: 36718731
- PubMed abstract
- Source abstract
-
- Cancer prevention in cancer predisposition syndromes: A protocol for testing the feasibility of building a hereditary cancer research registry and nurse navigator follow up model.
- Etchegary H, Pike A, Puddester R, Watkins K, Warren M, Francis V, Woods M, Green J, Savas S, Seal M, Gao Z, Avery S, Curtis F, McGrath J, MacDonald D, Burry TN, Dawson L.
- PLoS One. 2022 Dec 22;17(12):e0279317. doi: 10.1371/journal.pone.0279317.
- PMID: 36548287
- PubMed abstract
- Study protocol
- Free PMC article
- Free Full Text
-
- Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Non-carriers.
- Lewinsohn R, Zheng Y, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Peppercorn J, Borges VF, Come S, Snow C, Ginsburg ES, Partridge AH.
- Clin Breast Cancer. 2022 Dec 21:S1526-8209(22)00290-7. doi: 10.1016/j.clbc.2022.12.012. Epub ahead of print.
•• Identifier: NCT01468246: The Young Women's Breast Cancer Study (HOHO). (ClinicalTrials.gov . Accessed 2022 Dec 21.)
-
- Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.
- Lieberenz J, Levy M, Alvarado R, Paul S, Cobleigh M, Usha L, Stempel L.
- J Am Coll Radiol. 2022 Dec 11:S1546-1440(22)00895-X. doi: 10.1016/j.jacr.2022.11.010. Epub ahead of print.
- PMID: 36516954
- PubMed abstract
- Source abstract
-
- What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
- Frey MK, Ahsan MD, Badiner N, Lin J, Narayan P, Nitecki R, Rauh-Hain JA, Moss H, Fowlkes RK, Thomas C, Bergeron H, Christos P, Levi SR, Blank SV, Holcomb K, Cantillo E, Sharaf RN, Lipkin S, Offit K, Chapman-Davis E.
- Cancer. 2022 Oct 27. doi: 10.1002/cncr.34482. Epub ahead of print.
- PMID: 36305018
- PubMed abstract
- Source abstract
-
- Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania.
- Felbor U, Bülow R, Schmutzler RK, Rath M.
- Healthcare (Basel). 2022 Oct 13;10(10):2021. doi: 10.3390/healthcare10102021.
- PMID: 36292468
- PubMed abstract
- Source abstract
-
- Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system.
- Powell CB, Laurent C, Garcia C, Hoodfar E, Karlea A, Kobelka C, Lee J, Roh J, Kushi LH.
- Gynecol Oncol. 2022 Oct 8:S0090-8258(22)01857-1. doi: 10.1016/j.ygyno.2022.10.001. Epub ahead of print.
- PMID: 36220669
- PubMed abstract
- Source abstract
-
- Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes.
- Makhnoon S, Chen M, Levin B, Ensinger M, Mattie KD, Grana G, Shete S, Arun BK, Peterson SK.
- Cancer. 2022 Oct;128(20):3709-3717. doi: 10.1002/cncr.34429. Epub 2022 Aug 23.
- PMID: 35996941
- PubMed abstract
- Source abstract
-
- Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
- Whitworth PW, Beitsch PD, Patel R, Rosen B, Compagnoni G, Baron PL, Simmons R, Brown EA, Gold L, Holmes D, Smith LA, Kinney M, Grady I, Clark P, Barbosa K, Lyons S, Riley L, Coomer C, Curcio L, Ruiz A, Khan S, MacDonald H, Hughes K, Hardwick MK, Heald B, Munro SB, Nielsen SM, Esplin ED.
- JAMA Netw Open. 2022 Sep 1 [2022 Sep 22];5(9):e2232787. doi: 10.1001/jamanetworkopen.2022.32787.
- PMID: 36136330
- PubMed abstract
Research news: Universal Genetic Testing in Breast Cancer Further Supported in New Invitae-Led Study. (GenomeWeb)
Research news: Time for Universal Germline Genetic Testing in Breast Cancer. (Medscape)
-
- Hereditary Breast and Ovarian Cancer Genetic Risk: Screening and Treatment Among Transgender and Gender Diverse Patients.
- Sakradse M, Zhu S, Ritterman Weintraub M, Jung J, Zaritsky E.
- Perm J. 2022 Sep 14;26(3):30-38. doi: 10.7812/TPP/21.133. Epub 2022 Jul 28.
- PMID: 35939630
- PubMed abstract
- Source abstract
-
- GeneHome - a Novel Model to Deliver Care to Individuals with Genetic Predisposition to Cancer.
- Nocera Zachariah N, Lee MC, Chang MD, Moore C, Wang X.
- Cancer Control. 2022 Jan-Dec [First published 2022 Aug 17];29:10732748221109951. doi: 10.1177/10732748221109951.
- PMID: 35976772
- PubMed abstract
- Source abstract
-
- BI-RADS-0 screening mammography: Risk factors that prevent or delay follow-up time to diagnostic evaluation.
- Platt S, Montgomery GH, Schnur JH, Margolies L.
- J Am Coll Radiol. 2022 Aug 16:S1546-1440(22)00576-2. doi: 10.1016/j.jacr.2022.07.006. Epub ahead of print.
- PMID: 35985631
- PubMed abstract
- Source abstract
Commentary:
Reducing Disparities in Timely Follow-Up after an Abnormal Screening Mammogram.
-
- Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.
- Knerr S, Guo B, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Goddard KAB, Devine B.
- Cancer. 2022 Aug 15;128(16):3090-3098. doi: 10.1002/cncr.34349. Epub 2022 Jun 9.
- PMID: 35679147
- PubMed abstract
- Source abstract
-
- Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study.
- French DP, McWilliams L, Howell A, Evans DG.
- Breast. 2022 Aug;64:47-49. doi: 10.1016/j.breast.2022.05.001. Epub 2022 May 9.
- PMID: 35569186
- PubMed abstract
-
- Surveillance mammography after treatment for male breast cancer.
- Yadav S, Sangaralingham L, Payne SR, Giridhar KV, Hieken TJ, Boughey JC, Mutter RW, Hawse JR, Jimenez RE, Freedman RA, Khanani S, Couch FJ, Vachon C, Shah N, Leon-Ferre RA, Ruddy KJ.
- Breast Cancer Res Treat. 2022 Aug;194(3):693-698. doi: 10.1007/s10549-022-06645-w. Epub 2022 Jun 17.
- PMID: 35713802
- PubMed abstract
- Source abstract
-
- Toward a better understanding of the experience of patients with moderate penetrance breast cancer gene pathogenic/likely pathogenic variants: A focus on ATM and CHEK2.
- McCormick S, Hicks S, Wooters M, Grant C.
- J Genet Couns. 2022 Aug;31(4):956-964. doi: 10.1002/jgc4.1568. Epub 2022 Mar 4.
- PMID: 35246915
- PubMed abstract
- Source abstract
-
- Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting.
- Jürgens H, Roht L, Leitsalu L, Nõukas M, Palover M, Nikopensius T, Reigo A, Kals M, Kallak K, Kütner R, Budrikas K, Kuusk S, Valvere V, Laidre P, Toome K, Rekker K, Tooming M, Ülle Murumets, Kahre T, Kruuv-Käo K, Õunap K, Padrik P, Metspalu A, Esko T, Fischer K, Tõnisson N.
- Front Genet. 2022 Jul 22;13:881100. doi: 10.3389/fgene.2022.881100.
- PMID: 35938029
- PubMed abstract
-
- Contraception and Hormone Replacement Therapy in Healthy Carriers of Germline BRCA1/2 Genes Pathogenic Variants: Results from an Italian Survey.
- Massarotti C, Buonomo B, Dellino M, Campanella M, De Stefano C, Ferrari A, Anserini P, Lambertini M, Peccatori FA.
- Cancers (Basel). 2022 Jul 15;14(14):3457. doi: 10.3390/cancers14143457.
- PMID: 35884518
- PubMed abstract
- Source abstract
-
- The Clinical and Psychosocial Outcomes for Women Who Received Unexpected Clinically Actionable Germline Information Identified through Research: An Exploratory Sequential Mixed-Methods Comparative Study.
- Forrest LE, Forbes Shepherd R, Tutty E, Pearce A, Campbell I, Devereux L, Trainer AH, James PA, Young MA.
- J Pers Med. 2022 Jul 7;12(7):1112. doi: 10.3390/jpm12071112.
- PMID: 35887609
- PubMed abstract
- Source abstract
-
- Randomised trial of population based BRCA testing in Ashkenazi Jews: Long term secondary lifestyle behavioural outcomes.
- Burnell M, Gaba F, Sobocan M, Desai R, Sanderson S, Loggenberg K, Gessler S, Side L, Brady AF, Dorkins H, Wallis Y, Jacobs C, Legood R, Beller U, Tomlinson I, Wardle J, Menon U, Jacobs I, Manchanda R.
- BJOG. 2022 Jul 4. doi: 10.1111/1471-0528.17253. Epub ahead of print.
- PMID: 35781768
- PubMed abstract
- Source abstract
-
- Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006-2016.
- Adolph L, Warias A, Stairs J, Collins-McNeil K, Penney L, Kieser K.
- BMC Womens Health. 2022 Jun 29;22(1):263. doi: 10.1186/s12905-022-01844-5.
- PMID: 35768821
- PubMed abstract
-
- Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature.
- Carlsson L, Thain E, Gillies B, Metcalfe K.
- Hered Cancer Clin Pract. 2022 Jun 22;20(1):25. doi: 10.1186/s13053-022-00229-x.
- PMID: 35733200
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- A review of fertility preservation in patients with breast cancer.
- Ulrich ND, Raja NS, Moravek MB.
- Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:60-68. doi: 10.1016/j.bpobgyn.2022.01.004. Epub 2022 Jan 15.
- PMID: 35120831
- PubMed abstract
- Source abstract
-
- Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access.
- Amendola LM, Shuster E, Leo MC, Dorschner MO, Rolf BA, Shirts BH, Gilmore MJ, Okuyama S, Zepp JM, Kauffman TL, Mittendorf KF, Bellcross C, Jenkins CL, Joseph G, Riddle L, Syngal S, Ukaegbu C, Goddard KAB, Wilfond BS, Jarvik GP; CHARM Study.
- Genet Med. 2022 Jun;24(6):1196-1205. doi: 10.1016/j.gim.2022.02.006. Epub 2022 Mar 16.
- PMID: 35305866
- PubMed abstract
-
- Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.
- Archer S, Fennell N, Colvin E, Laquindanum R, Mills M, Dennis R, Stutzin Donoso F, Gold R, Fan A, Downes K, Ford J, Antoniou AC, Kurian AW, Evans DG, Tischkowitz M.
- Cancers (Basel). 2022 May 31;14(11):2716. doi: 10.3390/cancers14112716.
- PMID: 35681696
- PubMed abstract
- Source abstract
- Study protocol
- Free PMC article
- Free Full Text
-
- Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record.
- Elhanan G, Kiser D, Neveux I, Dabe S, Bolze A, Metcalf WJ, Lu JT, Grzymski JJ.
- Front Genet. 2022 Apr 27;13:866169. doi: 10.3389/fgene.2022.866169.
- PMID: 35571025
- PubMed abstract
-
- Preimplantation genetic testing in patients with genetic susceptibility to cancer.
- Villy MC, Frydman N, Moutou C, Thierry G, Raad J, Colas C, Steffann J, Metras J, Chabbert-Buffet N, Parc Y, Richard S, Benusiglio PR.
- Fam Cancer. 2022 Apr 12. doi: 10.1007/s10689-022-00293-1. Epub ahead of print.
- PMID: 35415820
- PubMed abstract
- Source abstract
-
- Demographic Differences Among US Department of Veterans Affairs Patients Referred for Genetic Consultation to a Centralized VA Telehealth Program, VA Medical Centers, or the Community.
- Scheuner MT, Huynh AK, Chanfreau-Coffinier C, Lerner B, Gable AR, Lee M, Simon A, Coeshott R, Hamilton AB, Patterson OV, DuVall S, Russell MM.
- JAMA Netw Open. 2022 Apr 1;5(4):e226687. doi: 10.1001/jamanetworkopen.2022.6687.
- PMID: 35404460
- PubMed abstract
-
- Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer.
- Ro V, McGuinness JE, Guo B, Trivedi MS, Jones T, Chung WK, Rao R, Levinson E, Koval C, Russo D, Chilton I, Kukafka R, Crew KD.
- JCO Oncol Pract. 2022 Apr;18(4):e472-e483. doi: 10.1200/OP.21.00322. Epub 2021 Oct 27.
- PMID: 34705516
- PubMed abstract
- Source abstract
-
- The Breast Cancer Screening and Timing of Breast MRI-Experience in a Genetic High-Risk Screening Clinic in a Comprehensive Cancer Center.
- Wang X, Chang MD, Lee MC, Niell BL.
- Curr Oncol. 2022 Mar 19;29(3):2119-2131. doi: 10.3390/curroncol29030171.
- PMID: 35323371
- PubMed abstract
- Source abstract
-
- Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers.
- Sandoval RL, Polidorio N, Leite ACR, Cartaxo M, Pisani JP, Quirino CV, Cezana L, Pereira NG, Pereira AAL, Rossi BM, Achatz MI.
- Front Oncol. 2022 Mar 16;12:836937. doi: 10.3389/fonc.2022.836937.
- PMID: 35371985
- PubMed abstract
-
- Impact of BRCA Status on Reproductive Decision-Making and Self-Concept: A Mixed-Methods Study Informing the Development of Tailored Interventions.
- Hesse-Biber S, Seven M, Jiang J, Schaik SV, Dwyer AA.
- Cancers (Basel). 2022 Mar 15;14(6):1494. doi: 10.3390/cancers14061494.
- PMID: 35326645
- PubMed abstract
- Source abstract
-
- Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.
- Horton C, Blanco K, Lo MT, Speare V, LaDuca H, Dolinsky JS, Kurian AW.
- JNCI Cancer Spectr. 2022 Mar 2;6(2):pkac002. doi: 10.1093/jncics/pkac002.
- PMID: 35603838
- PubMed abstract
-
- Residential Locale Is Associated with Disparities in Genetic Testing-Related Outcomes Among BRCA1/2-Positive Women.
- Dibble KE, Connor AE.
- J Racial Ethn Health Disparities. 2022 Feb 17. doi: 10.1007/s40615-022-01259-w. Epub ahead of print.
- PMID: 35178668
- PubMed abstract
-
- Earlier decisions on breast and ovarian surgery reduce cancer in women at high risk.
- Saul H, Gursul D, Cassidy S, Evans G.
- BMJ. 2022 Feb 15;376:o258. doi: 10.1136/bmj.o258.
- PMID: 35168943
- PubMed abstract
- Source abstract
Original research:
Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
- PMID: 33568438
- PubMed abstract
- Source abstract
-
- Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
- Marcinkute R, Woodward ER, Gandhi A, Howell S, Crosbie EJ, Wissely J, Harvey J, Highton L, Murphy J, Holland C, Edmondson R, Clayton R, Barr L, Harkness EF, Howell A, Lalloo F, Evans DG.
- J Med Genet. 2022 Feb;59(2):133-140. doi: 10.1136/jmedgenet-2020-107356. Epub 2021 Feb 10.
- PMID: 33568438
- PubMed abstract
- Source abstract
Research news:
Earlier decisions on breast and ovarian surgery reduce cancer in women at high risk.
- PMID: 35168943
- PubMed abstract
- Source abstract
-
- Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li-Fraumeni syndrome.
- Siegel A, Bremer RC, Klein WMP, Savage SA, Loud JT, Khincha PP.
- Breast Cancer Res Treat. 2022 Jan;191(1):159-167. doi: 10.1007/s10549-021-06410-5. Epub 2021 Oct 15.
- PMID: 34652547
- PubMed abstract
- Source abstract
-
- Genetic testing in Non-Hispanic Black women with breast cancer treated within an equal-access healthcare system.
- Vargason AB, Turner CE, Shriver CD, Ellsworth RE.
- Genet Med. 2022 Jan;24(1):232-237. doi: 10.1016/j.gim.2021.08.002. Epub 2021 Nov 30.
- PMID: 34906450
- PubMed abstract
Podcast: January 2022: Providing access to quality healthcare for Non-Hispanic Black women reduces mortality. (Genetics in Medicine. GenePod)
-
- Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.
- John CS, Fong A, Alban R, Gillen J, Moore KM, Walsh CS, Li AJ, Rimel BJ, Amersi F, Cass I.
- Gynecol Oncol. 2022 Jan;164(1):202-207. doi: 10.1016/j.ygyno.2021.10.077. Epub 2021 Nov 30.
- PMID: 34862065
- PubMed abstract
- Source abstract
-
- Genetic testing for hereditary predisposition to breast cancer in the real world: Initial experience.
- da Silva Fontinele DR, Assunção Ribeiro da Costa RE, da Silva Magalhães MK, Vieira SC.
- Breast Dis. 2022;41(1):249-254. doi: 10.3233/BD-210082.
- PMID: 35570472
- PubMed abstract
- Source abstract
-
- Genetic Counseling, Screening and Risk-Reducing Surgery in Patients with Primary Breast Cancer and Germline BRCA Mutations: Unmet Needs in Low- and Middle-Income Countries.
- Moukadem HA, Al Masry A, Atwani RW, Kreidieh F, Khalil LE, Saroufim R, Daouk S, Dalle IA, El Saghir NS.
- Eur J Breast Health. 2021 Dec 30;18(1):16-20. doi: 10.4274/ejbh.galenos.2021.2021-5-1.
- PMID: 35059587
- PubMed abstract
- Source abstract
-
- Underutilisation of breast cancer prevention medication in Australia.
- Macdonald C, Chamberlain JA, Mazza D, Milne RL; kConFab investigators, Phillips KA.
- Breast. 2021 Dec;60:35-37. doi: 10.1016/j.breast.2021.08.013. Epub 2021 Aug 23.
- PMID: 34455228
- PubMed abstract
-
- Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer.
- Evans DG, Gandhi A, Wisely J, Clancy T, Woodward ER, Harvey J, Highton L, Murphy J, Barr L, Howell SJ, Lalloo F, Harkness EF, Howell A.
- Breast. 2021 Dec;60:45-52. doi: 10.1016/j.breast.2021.08.015. Epub 2021 Aug 26.
- PMID: 34464846
- PubMed abstract
-
- Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior.
- Yanes T, Meiser B, Kaur R, Young MA, Mitchell PB, Scheepers-Joynt M, McInerny S, Taylor S, Barlow-Stewart K, Antill Y, Salmon L, Smyth C, Betz-Stablein B, James PA.
- Genet Med. 2021 Dec;23(12):2316-2323. doi: 10.1038/s41436-021-01288-6. Epub 2021 Aug 2.
- PMID: 34341522
- PubMed abstract
- Source abstract
Podcast: GenePod—November: The potential impact of a PRS-based breast cancer risk assessment. (Genetics in Medicine)
-
- Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities.
- Mittendorf KF, Knerr S, Kauffman TL, Lindberg NM, Anderson KP, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Zepp JM, Syngal S, Wilfond BS, Goddard KAB.
- JCO Precis Oncol. 2021 Nov 3;5:PO.21.00233. doi: 10.1200/PO.21.00233.
- PMID: 34778694
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance.
- Grandi G, Fiocchi F, Cortesi L, Toss A, Boselli F, Sammarini M, Sighinolfi G, Facchinetti F.
- Menopause. 2021 Nov 1;29(1):63-72. doi: 10.1097/GME.0000000000001883.
- PMID: 34726192
- PubMed abstract
-
- Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1/2 mutations.
- Smith MJ, Gerber D, Olsen A, Khouri OR, Wang Y, Liu M, Smith J, Pothuri B.
- Am J Obstet Gynecol. 2021 Nov;225(5):508.e1-508.e10. doi: 10.1016/j.ajog.2021.06.070. Epub 2021 Jun 23.
- PMID: 34171390
- PubMed abstract
- Source abstract
-
- November: The potential impact of a PRS-based breast cancer risk assessment.
- Yanes T, Graber C.
- Genetics in Medicine. GenePod. 2021 Nov.
- Podcast
- SoundCloud
- Audio
Original research:
Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior.
- PMID: 34341522
- PubMed abstract
- Source abstract
-
- The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
- Greer AC, Lanes A, Poorvu PD, Kennedy P, Thomas AM, Partridge AH, Ginsburg ES.
- Cancer. 2021 Oct 15;127(20):3872-3880. doi: 10.1002/cncr.33601. Epub 2021 Jun 23.
- PMID: 34161610
- PubMed abstract
- Source abstract
-
- IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.
- Cragun D, Beckstead J, Farmer M, Hooker G, Dean M, Matloff E, Reid S, Tezak A, Weidner A, Whisenant JG, Pal T.
- BMC Cancer. 2021 Oct 13;21(1):1099. doi: 10.1186/s12885-021-08822-4.
- PMID: 34645413
- PubMed abstract
-
- Disparities between Uptake of Germline BRCA1/2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients.
- Hur YM, Mun J, Kim MK, Lee M, Kim YH, Kim SC.
- J Korean Med Sci. 2021 Oct 4;36(38):e241. doi: 10.3346/jkms.2021.36.e241.
- PMID: 34609091
- PubMed abstract
- Source abstract
-
- Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
- Mittal A, Deo SVS, Gogia A, Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Thulkar S, Ramprasad VL, Olopade O, Pramanik R.
- Ann Surg Oncol. 2021 Oct 2:1–10. doi: 10.1245/s10434-021-10870-w. Epub ahead of print.
- PMID: 34601666
- PubMed abstract
-
- Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.
- Makhnoon S, Tran G, Levin B, Mattie KD, Dreyer B, Volk RJ, Grana G, Arun BK, Peterson SK.
- Cancer. 2021 Oct 1;127(19):3605-3613. doi: 10.1002/cncr.33668. Epub 2021 Jun 22.
- PMID: 34157779
- PubMed abstract
- Source abstract
-
- Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system.
- Nañez A, Stram DA, Garcia C, Powell CB.
- Gynecol Oncol. 2021 Oct;163(1):134-141. doi: 10.1016/j.ygyno.2021.07.034. Epub 2021 Jul 27.
- PMID: 34330534
- PubMed abstract
- Source abstract
-
- Contralateral prophylactic mastectomy in the setting of breast cancer diagnosis and their insurance coverage in the United States.
- Ha M, Ngaage LM, Klein M, Yang A, Colohan SM, Nurudeen SM, Terhune JH, Slezak S, Rasko YM.
- Breast J. 2021 Sep 15. doi: 10.1111/tbj.14280. Epub ahead of print.
- PMID: 34528334
- PubMed abstract
- Source abstract
-
- Association of Population Screening for Breast Cancer Risk With Use of Mammography Among Women in Medically Underserved Racial and Ethnic Minority Groups.
- Schwartz C, Chukwudozie IB, Tejeda S, Vijayasiri G, Abraham I, Remo M, Shah HA, Rojas M, Carillo A, Moreno L, Warnecke RB, Hoskins KF.
- JAMA Netw Open. 2021 Sep 1;4(9):e2123751. doi: 10.1001/jamanetworkopen.2021.23751.
- PMID: 34505886
- PubMed abstract
Commentary:
Practice-Changing Opportunity to Reduce Disparities in Screening Mammography-Implementation of Risk Assessment in Primary Care.
- PMID: 34505890
- PubMed abstract
- Free Full Text
-
- Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
- Steenbeek MP, van Bommel MHD, Harmsen MG, Hoogerbrugge N, van Doorn HC, Keurentjes JHM, van Beurden M, Zweemer RP, Gaarenstroom KN, Penders CGJ, Brood-van Zanten MMA, Vos MC, Piek JM, van Lonkhuijzen LRCW, Apperloo MJA, Coppus SFPJ, IntHout J, de Hullu JA, Hermens RPMG.
- Gynecol Oncol. 2021 Aug 26:S0090-8258(21)01317-2. doi: 10.1016/j.ygyno.2021.08.019. Epub ahead of print.
- PMID: 34456057
- PubMed abstract
-
- Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea.
- Park B, Kim D, Kim J, Lee BY, Yoon J, Kim SW.
- Cancer Res Treat. 2021 Aug 9. doi: 10.4143/crt.2021.449. Epub ahead of print.
- PMID: 34384016
- PubMed abstract
- Source abstract
-
- EUS-based pancreatic cancer surveillance in BRCA1/BRCA2/PALB2/ATM carriers without a family history of pancreatic cancer.
- Katona BW, Long JM, Ahmad NA, Attalla S, Bradbury AR, Carpenter EL, Clark DF, Constantino G, Das KK, Domchek SM, Dudzik C, Ebrahimzadeh J, Ginsberg GG, Heiman J, Kochman ML, Maxwell KN, McKenna DB, Powers J, Shah PD, Wangensteen KJ, Rustgi AK.
- Cancer Prev Res (Phila). 2021 Aug 2:canprevres.0161.2021. doi: 10.1158/1940-6207.CAPR-21-0161. Epub ahead of print.
- PMID: 34341011
- PubMed abstract
- Source abstract
-
- Cancer surveillance awareness and practice among families at increased risk for pancreatic adenocarcinoma.
- Everett JN, Burgos G, Chun J, Baptiste A, Khanna LG, Oberstein PE, Simeone DM.
- Cancer. 2021 Jul 1;127(13):2271-2278. doi: 10.1002/cncr.33500. Epub 2021 Mar 15.
- PMID: 33721345
- PubMed abstract
- Source abstract
-
- Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives.
- Abdel-Razeq H, Tamimi F, Abujamous L, Edaily S, Abunasser M, Bater R, Salama O.
- Cancer Manag Res. 2021 Jun 9;13:4597-4604. doi: 10.2147/CMAR.S316470.
- PMID: 34135636
- PubMed abstract
-
- Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network.
- Fan X, Wynn J, Shang N, Liu C, Fedotov A, Hallquist MLG, Buchanan AH, Williams MS, Smith ME, Hoell C, Rasmussen-Torvik LJ, Peterson JF, Wiesner GL, Murad AM, Jarvik GP, Gordon AS, Rosenthal EA, Stanaway IB, Crosslin DR, Larson EB, Leppig KA, Henrikson NB, Williams JL, Li R, Hebbring S, Weng C, Shen Y, Crew KD, Chung WK.
- JNCI Cancer Spectr. 2021 May 8;5(4):pkab044. doi: 10.1093/jncics/pkab044.
- PMID: 34377931
- PubMed abstract
-
- CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects.
- Apostolou P, Dellatola V, Papadimitriou C, Kalfakakou D, Fountzilas E, Faliakou E, Fountzilas G, Romanidou O, Konstantopoulou I, Fostira F.
- Cancers (Basel). 2021 Apr 27;13(9):2106. doi: 10.3390/cancers13092106.
- PMID: 33925588
- PubMed abstract
- Source abstract
-
- High-risk women are facing barriers to preventive breast cancer care.
- Branigin A.
- Washington Post. The Lily. 2021 Apr 27.
- Research News
- Free Full Text
Original research:
Financial constraints on genetic counseling and further risk-management decisions among U.S. women at elevated breast cancer risk.
- PMID: 33749063
- PubMed abstract
- Source abstract
-
- The PREgnancy and FERtility (PREFER) study investigating the need for ovarian function and/or fertility preservation strategies in premenopausal women with early breast cancer.
- Blondeaux E, Massarotti C, Fontana V, Poggio F, Arecco L, Fregatti P, Bighin C, Giannubilo I, Ruelle T, Razeti MG, Boni L, Anserini P, Del Mastro L, Lambertini M.
- Front Oncol. 2021 Apr 26;10:690320. doi: 10.3389/fonc.2021.690320.
-
- The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada.
- Narod SA, Gojska N, Sun P, Tryon A, Kotsopoulos J, Metcalfe K, Akbari MR.
- Cancers (Basel). 2021 Apr 15;13(8):1894. doi: 10.3390/cancers13081894.
- PMID: 33920818
- PubMed abstract
- Source abstract
-
- Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.
- Makhnoon S, Bednar EM, Krause KJ, Peterson SK, Lopez-Olivo MA.
- Clin Genet. 2021 Apr 12. doi: 10.1111/cge.13966. Epub ahead of print.
- PMID: 33843052
- PubMed abstract
- Free Full Text
-
- Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.
- Meiser B, Kaur R, Morrow A, Peate M, Wong WKT, McPike E, Cops E, Nichols C, Austin R, Fine M, Thrupp L, Ward R, Macrae F, Hiller JE, Trainer AH, Mitchell G; ICCon Audit Study Collaborative Group.
- Hered Cancer Clin Pract. 2021 Apr 9;19(1):24. doi: 10.1186/s13053-021-00180-3.
- PMID: 33836815
- PubMed abstract
-
- Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
- Ložar T, Žgajnar J, Perhavec A, Blatnik A, Novakovic S, Krajc M.
- Eur J Surg Oncol. 2021 Mar 26:S0748-7983(21)00393-0. doi: 10.1016/j.ejso.2021.03.248. Epub ahead of print.
- PMID: 33812767
- PubMed abstract
-
- Financial constraints on genetic counseling and further risk-management decisions among U.S. women at elevated breast cancer risk.
- Meadows RJ, Padamsee TJ.
- J Genet Couns. 2021 Mar 21. doi: 10.1002/jgc4.1413. Epub ahead of print.
- PMID: 33749063
- PubMed abstract
- Source abstract
Press: High-risk women are facing barriers to preventive breast cancer care. (Washington Post / The Lily)
-
- Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
- Seppälä TT, Dominguez-Valentin M, Crosbie EJ, Engel C, Aretz S, Macrae F, Winship I, Capella G, Thomas H, Hovig E, Nielsen M, Sijmons RH, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Mints M, Gluck N, Katz L, Heinimann K, Vaccaro CA, Green K, Lalloo F, Hill J, Schmiegel W, Vangala D, Perne C, Strauß HG, Tecklenburg J, Holinski-Feder E, Steinke-Lange V, Mecklin JP, Plazzer JP, Pineda M, Navarro M, Vida JB, Kariv R, Rosner G, Piñero TA, Pavicic W, Kalfayan P, Ten Broeke SW, Jenkins MA, Sunde L, Bernstein I, Burn J, Greenblatt M, de Vos Tot Nederveen Cappel WH, Della Valle A, Lopez-Koestner F, Alvarez K, Büttner R, Görgens H, Morak M, Holzapfel S, Hüneburg R, von Knebel Doeberitz M, Loeffler M, Redler S, Weitz J, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Hopper JL, Win AK, Lindor NM, Gallinger S, Le Marchand L, Newcomb PA, Figueiredo JC, Thibodeau SN, Therkildsen C, Wadt KAW, Mourits MJE, Ketabi Z, Denton OG, Rødland EA, Vasen H, Neffa F, Esperon P, Tjandra D, Möslein G, Rokkones E, Sampson JR, Evans DG, Møller P.
- Eur J Cancer. 2021 Mar 17;148:124-133. doi: 10.1016/j.ejca.2021.02.022. Epub ahead of print.
- PMID: 33743481
- PubMed abstract
-
- Abnormal screens among nonmutation carriers in the High Risk Ontario Breast Screening Program.
- Castelo M, Brown Z, Schellenberg AE, Mills JK, Eisen A, Muradali D, Grunfeld E, Scheer AS.
- Breast J. 2021 Feb 7. doi: 10.1111/tbj.14185. Epub ahead of print.
- PMID: 33550650
- PubMed abstract
- Source abstract
-
- The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer.
- Basu NN, Hodson J, Chatterjee S, Gandhi A, Wisely J, Harvey J, Highton L, Murphy J, Barnes N, Johnson R, Barr L, Kirwan CC, Howell S, Baildam AD, Howell A, Evans DG.
- Sci Rep. 2021 Feb 2;11(1):2847. doi: 10.1038/s41598-021-82654-x.
- PMID: 33531640
- PubMed abstract
-
- Development and Implementation of an Algorithm to Guide MRI Screening in Patients With a Personal History of Treated Breast Cancer.
- Strigel RM, Bravo E, Tevaarwerk AJ, Anderson BM, Stella AL, Neuman HB.
- Clin Breast Cancer. 2021 Feb;21(1):26-30. doi: 10.1016/j.clbc.2020.01.005. Epub 2020 Oct 17.
- PMID: 33162349
- PubMed abstract
- Source abstract
-
- A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
- Inuzuka M, Watanabe C, Yokoyama S, Kuwayama T, Akashi-Tanaka S, Arai M, Nakamura S; Registration Committee of the Japanese HBOC consortium.
- Clin Breast Cancer. 2021 Feb;21(1):e48-e52. doi: 10.1016/j.clbc.2020.08.004. Epub 2020 Aug 20.
- PMID: 32928640
- PubMed abstract
- Source abstract
-
- Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.
- Gaddam S, Heller SL, Babb JS, Gao Y.
- Clin Breast Cancer. 2021 Feb;21(1):e74-e79. doi: 10.1016/j.clbc.2020.07.014. Epub 2020 Jul 25.
- PMID: 32828665
- PubMed abstract
- Source abstract
-
- Implementation of a High-Risk Breast Clinic for Comprehensive Care of Women With Elevated Breast Cancer Risk Identified by Risk Assessment Models in the Community.
- Laws A, Mulvey TM.
- JCO Oncol Pract. 2021 Feb;17(2):e217-e225. doi: 10.1200/OP.20.00256. Epub 2020 Aug 21.
- PMID: 32822256
- PubMed abstract
- Source abstract
-
- Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers.
- Eikenboom EL, van Doorn HC, Dinjens WNM, Dubbink HJ, Geurts-Giele WRR, Spaander MCW, Tops CMJ, Wagner A, Goverde A.
- Cancers (Basel). 2021 Jan 26;13(3):459. doi: 10.3390/cancers13030459.
- PMID: 33530354
- PubMed abstract
- Source abstract
-
- Prophylactic Surgery in the BRCA+ Patient: Do Women Develop Breast Cancer While Waiting?
- Macadam SA, Slater K, Cheifetz RE, Jansen L, Chia S, Brasher PMA, Bovill ES.
- Curr Oncol. 2021 Jan 25;28(1):702-715. doi: 10.3390/curroncol28010069.
- PMID: 33504079
- PubMed abstract
- Source abstract
-
- Screening and Preventative Strategies for Patients at High Risk for Breast Cancer.
- Ter-Minassian M, Schaeffer ML, Jefferson CR, Shapiro SC, Suwannarat P, Visvanathan K.
- JCO Oncol Pract. 2021 Jan 11:OP2000262. doi: 10.1200/OP.20.00262. Epub ahead of print.
- PMID: 33428469
- PubMed abstract
- Source abstract
-
- Identification of factors that influence the decision to take chemoprevention in patients with a significant family history of breast cancer: results from a patient questionnaire survey.
- Jones S, Hogan B, Patel K, Ooi S, Turton P, Achuthan R, Kim B.
- Breast Cancer Res Treat. 2021 Jan 3. doi: 10.1007/s10549-020-06046-x. Epub ahead of print.
- PMID: 33389407
- PubMed abstract
- Source abstract
-
- Why is appropriate healthcare inaccessible for many European breast cancer patients? - The EBCC 12 manifesto.
- Cardoso F, MacNeill F, Penault-Llorca F, Eniu A, Sardanelli F, Nordström EB, Poortmans P.
- Breast. 2021 Jan 2;55:128-135. doi: 10.1016/j.breast.2020.12.010. Epub ahead of print.
- PMID: 33461060
- PubMed abstract
-
- Breast Cancer Chemoprevention: Use and Views of Australian Women and their Clinicians.
- Macdonald C, Saunders CM, Keogh LA, Hunter M, Mazza D, McLachlan SA, Jones SC, Nesci S, Friedlander ML, Hopper JL, Emery JD, Hickey M, Milne RL, Phillips KA; Kathleen Cuningham Consortium for Research Into Familial Breast Cancer.
- Cancer Prev Res (Phila). 2021 Jan;14(1):131-144. doi: 10.1158/1940-6207.CAPR-20-0369. Epub 2020 Oct 28.
- PMID: 33115784
- PubMed abstract
Commentary:
Implementation of Risk-reducing Strategies for Breast Cancer is Long Overdue.
- PMID: 33177071
- PubMed abstract
- Free Full Text
-
- Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer: a cross-sectional survey in England.
- Lee SI, Curtis H, Qureshi S, Dutton B, Qureshi N.
- J Community Genet. 2021 Jan;12(1):111-120. doi: 10.1007/s12687-020-00490-4. Epub 2020 Oct 28.
- PMID: 33118147
- PubMed abstract
-
- Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?
- Grandi G, Perrone AM, Perrone A, Mandato VD, Comerci G, Sammarini M, Merisio C, Amadori A, Stefanetti M, Martinello R, Facchinetti F, De Iaco P; Brca Emilia-Romagna Gyneco-Oncological (BERGO) Collaborative Group.
- Maturitas. 2021 Jan;143:59-64. doi: 10.1016/j.maturitas.2020.08.011. Epub 2020 Aug 31.
- PMID: 33308637
- PubMed abstract
- Source abstract
-
- The effect of family history on screening procedures and prognosis in breast cancer patients - Results of a large population-based case-control study.
- Seiffert K, Thoene K, Eulenburg CZ, Behrens S, Schmalfeldt B, Becher H, Chang-Claude J, Witzel I.
- Breast. 2020 Dec 24;55:98-104. doi: 10.1016/j.breast.2020.12.008. Epub ahead of print.
- PMID: 33395600
- PubMed abstract
-
- Study: Women support delayed removal of ovaries.
- [No author given]
- FORCE. XRAY. 2020 Dec 24.
- Research news
- Free Full Text
Original research:
Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
- PMID: 32803845
- PubMed abstract
- Free Full Text
-
- Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016.
- Wernli KJ, Callaway KA, Henderson LM, Kerlikowske K, Lee JM, Ross-Degnan D, Wallace JK, Wharam JF, Zhang F, Stout NK.
- Cancer. 2020 Dec 15;126(24):5293-5302. doi: 10.1002/cncr.33140. Epub 2020 Sep 28.
- PMID: 32985694
- PubMed abstract
-
- Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987-2020).
- Howell A, Gandhi A, Howell S, Wilson M, Maxwell A, Astley S, Harvie M, Pegington M, Barr L, Baildam A, Harkness E, Hopwood P, Wisely J, Wilding A, Greenhalgh R, Affen J, Maurice A, Cole S, Wiseman J, Lalloo F, French DP, Evans DG.
- Cancers (Basel). 2020 Dec 9;12(12):3697. doi: 10.3390/cancers12123697.
- PMID: 33317064
- PubMed abstract
- Source abstract
-
- Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation.
- Jung SM, Ryu JM, Park HS, Park JS, Kang E, Lee S, Lee HB, Youn HJ, Yoo TK, Kim J, Lee JE, Han SA, Kim D, Kim SW; Korean Hereditary Breast Cancer Study Group.
- J Breast Cancer. 2020 Dec 3;23(6):647-655. doi: 10.4048/jbc.2020.23.e61.
- PMID: 33408890
- PubMed abstract
- Source abstract
-
- Breast Cancer Mortality among Women with a BRCA1 or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program.
- Warner E, Zhu S, Plewes DB, Hill K, Ramsay EA, Causer PA, Seely J, Jong RA, Lenkov P, Elser C, Crystal P, Yaffe MJ, Giannakeas V, Sun P, Narod SA.
- Cancers (Basel). 2020 Nov 23;12(11):3479. doi: 10.3390/cancers12113479.
- PMID: 33238387
- PubMed abstract
- Source abstract
-
- Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants.
- Leitsalu L, Palover M, Sikka TT, Reigo A, Kals M, Pärn K, Nikopensius T, Esko T, Metspalu A, Padrik P, Tõnisson N.
- Eur J Hum Genet. 2020 Nov 23. doi: 10.1038/s41431-020-00760-2. Epub ahead of print.
- PMID: 33230308
- PubMed abstract
- Source abstract
-
- Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness.
- Lovejoy LA, Turner CE, Shriver CD, Ellsworth RE.
- Mil Med. 2020 Nov 18:usaa485. doi: 10.1093/milmed/usaa485. Epub ahead of print.
- PMID: 33206196
- PubMed abstract
-
- Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest.
- Worcester S.
- Medscape. News & Perspective. 2020 Oct 16.
- Research news
- Free Full Text
Original research:
Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
- PMID: 32803845
- PubMed abstract
- Free Full Text
-
- Young women's decision-making and experience of using tamoxifen to reduce BRCA1/2 breast cancer risk: a qualitative study.
- Forrest LE, Shepherd RF, Young MA, Keogh LA, James PA.
- Psychooncology. 2020 Oct 1. doi: 10.1002/pon.5556. Epub ahead of print.
- PMID: 33006205
- PubMed abstract
- Source abstract
-
- Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.
- Fong A, Cass I, John C, Gillen J, Moore KM, Gangi A, Walsh C, Li AJ, Rimel BJ, Karlan BY, Amersi F.
- Am Surg. 2020 Oct;86(10):1243-1247. doi: 10.1177/0003134820964208. Epub 2020 Oct 26.
- PMID: 33106023
- PubMed abstract
- Source abstract
-
- Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience.
- Bennett I, Tourani S, Cockburn L, Reasbeck J, Grobbelaar N, Dann S, Patrikios P, Brazier J.
- ANZ J Surg. 2020 Sep 30. doi: 10.1111/ans.16320. Epub ahead of print.
- PMID: 33000553
- PubMed abstract
- Source abstract
-
- Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers.
- Galmor L, Bernstein-Molho R, Sklair-Levy M, Madoursky-Feldman D, Zippel D, Laitman Y, Friedman E.
- Breast Cancer Res Treat. 2020 Sep 30. doi: 10.1007/s10549-020-05949-z. Epub ahead of print.
- PMID: 33000375
- PubMed abstract
- Source abstract
-
- Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.
- Bergstrom C, Pence C, Berg J, Partain N, Sadeghi N, Mauer C, Pirzadeh-Miller S, Gao A, Li H, Unni N, Syed S.
- Ann Surg Oncol. 2020 Sep 29. doi: 10.1245/s10434-020-09158-2. Epub ahead of print.
- PMID: 32996020
- PubMed abstract
- Source abstract
-
- Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation.
- Mansfield CA, Metcalfe KA, Snyder C, Lindeman GJ, Posner J, Friedman S; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Lynch HT, Narod SA, Evans DG, Liede A.
- Hered Cancer Clin Pract. 2020 Sep 29;18:20. doi: 10.1186/s13053-020-00152-z.
- PMID: 33014209
- PubMed abstract
-
- Genetic Testing and Surveillance of Young Breast Cancer Survivors and Blood Relatives: A Cluster Randomized Trial.
- Katapodi MC, Ming C, Northouse LL, Duffy SA, Duquette D, Mendelsohn-Victor KE, Milliron KJ, Merajver SD, Dinov ID, Janz NK.
- Cancers (Basel). 2020 Sep 5;12(9):2526. doi: 10.3390/cancers12092526.
- PMID: 32899538
- PubMed abstract
- Source abstract
-
- Strategies to enhance identification of hereditary breast cancer gene carriers.
- Reid S, Spalluto LB, Pal T.
- Expert Rev Mol Diagn. 2020 Aug 28. doi: 10.1080/14737159.2020.1816829. Epub ahead of print.
- PMID: 32856489
- PubMed abstract
- Editorial
- Free Full Text
-
- Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
- Gaba F, Blyuss O, Chandrasekaran D, Osman M, Goyal S, Gan C, Izatt L, Tripathi V, Esteban I, McNicol L, Ragupathy K, Crawford R, Evans DG, Legood R, Menon U, Manchanda R.
- BJOG. 2020 Aug 16. doi: 10.1111/1471-0528.16424. Epub ahead of print.
- PMID: 32803845
- PubMed abstract
- Source abstract
Commentary:
Attitudes towards risk-reducing salpingectomy: listen to the patients.
- PMID: 32892497
- PubMed abstract
- Source abstract
Press: Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest (Medscape. News & Perspective.)
Research news: Study: Women support delayed removal of ovaries (FORCE. XRAY.)
-
- Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
- Yin K, Singh P, Drohan B, Hughes KS.
- Cancer. 2020 Aug 4. doi: 10.1002/cncr.33113. Epub ahead of print.
- PMID: 32749697
- PubMed abstract
- Source abstract
-
- Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
- Murphy BL, Yi M, Arun BK, Gutierrez Barrera AM, Bedrosian I.
- Ann Surg Oncol. 2020 Jul 27. doi: 10.1245/s10434-020-08889-6. Epub ahead of print.
- PMID: 32720048
- PubMed abstract
- Source abstract
-
- Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
- Chapman-Davis E, Zhou ZN, Fields JC, Frey MK, Jordan B, Sapra KJ, Chatterjee-Paer S, Carlson AD, Holcomb KM.
- J Gen Intern Med. 2020 Jul 27. doi: 10.1007/s11606-020-06064-x. Epub ahead of print.
- PMID: 32720237
- PubMed abstract
- Source abstract
-
- Expectations of Surveillance for Non-BRCA Gene Mutation Carriers at Increased Risk for Breast Cancer.
- Caskey R, Singletary B, Ayre K, Parker C, Krontiras H, Lancaster RB.
- J Surg Res. 2020 Jul 23;256:267-271. doi: 10.1016/j.jss.2020.06.029. Epub ahead of print.
- PMID: 32712440
- PubMed abstract
- Source abstract
-
- Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations.
- Ming C, Viassolo V, Probst-Hensch N, Dinov ID, Chappuis PO, Katapodi MC.
- Br J Cancer. 2020 Jun 22. doi: 10.1038/s41416-020-0937-0. Epub ahead of print.
- PMID: 32565540
- PubMed abstract
-
- Improving primary care identification of familial breast cancer risk using proactive invitation and decision support.
- Qureshi N, Dutton B, Weng S, Sheehan C, Chorley W, Robertson JFR, Kendrick D, Kai J.
- Fam Cancer. 2020 Jun 11. doi: 10.1007/s10689-020-00188-z. Epub ahead of print.
- PMID: 32524330
- PubMed abstract
-
- Factors Impacting on Decision-Making towards Prophylactic Surgeries in BRCA Mutation Carriers and Women with Familial Predisposition.
- Segerer R, Peschel C, Kämmerer U, Häussler S, Wöckel A, Segerer S.
- Breast Care (Basel). 2020 Jun;15(3):253-259. doi: 10.1159/000503370. Epub 2019 Oct 1.
- PMID: 32774219
- PubMed abstract
- Source abstract
-
- Utilization of Complementary Alternative Medicine, Diet, and Exercise Among Women at High Risk for Developing Breast Cancer.
- Lee RT, Amico A, Malaka D, Lewin R, Cummings SA, Verp M, Patrick-Miller L, Bradbury AR, Olopade OI.
- Integr Cancer Ther. 2020 Jan-Dec;19:1534735420922610. doi: 10.1177/1534735420922610. [First Published 2020 May 23.]
- PMID: 32448019
- PubMed abstract
- Source abstract
-
- Factors associated with counseling and postoperative hormone therapy use in surgically menopausal women.
- Verrilli L, Brown H, Williams M.
- Menopause. 2020 May 11. doi: 10.1097/GME.0000000000001560. Epub ahead of print.
- PMID: 32404796
- PubMed abstract
- Source abstract
-
- Comparison of mammography behaviors, health beliefs, and fear levels of women with and without familial breast cancer history.
- Erdogan E, Tuzcu A.
- Women Health. 2020 Apr 6:1-16. doi: 10.1080/03630242.2020.1746949. [Epub ahead of print]
- PMID: 32252615
- PubMed abstract
- Source abstract
-
- Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients.
- Bradbury AR, Egleston BL, Patrick-Miller LJ, Rustgi N, Brandt A, Brower J, DiGiovanni L, Fetzer D, Berkelbach C, Long JM, Powers J, Stopfer JE, Domchek SM.
- Clin Genet. 2020 Apr;97(4):601-609. doi: 10.1111/cge.13716.
- PMID: 32022897
- PubMed abstract
- Source abstract
-
- Does Medicare-eligible high-risk breast cancer screening MRI target the right women?
- Lo G, McLaughlin A, Jacques A, Dhillon R, Porter G, Jayaratne T, Bose S, Bourke A.
- J Med Imaging Radiat Oncol. 2020 Apr;64(2):220-228. doi: 10.1111/1754-9485.13009. Epub 2020 Feb 9.
- PMID: 32037738
- PubMed abstract
- Source abstract
-
- Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
- Vriens IJH, Ter Welle-Butalid EM, de Boer M, de Die-Smulders CEM, Derhaag JG, Geurts SME, van Hellemond IEG, Luiten EJT, Dercksen MW, Lemaire BMD, van Haaren ERM, Vriens BEPJ, van de Wouw AJ, van Riel AMGH, Janssen-Engelen SLE, van de Poel MHW, Schepers-van der Sterren EEM, van Golde RJT, Tjan-Heijnen VCG.
- Breast Cancer Res Treat. 2020 Mar 31. doi: 10.1007/s10549-020-05598-2. [Epub ahead of print]
- PMID: 32236826
- PubMed abstract
Letter:
Fertility and reproduction in breast cancer patients.
- PMID: 32436144
- PubMed abstract
- Source abstract
-
- Uptake of Risk Appropriate Behaviors After Breast Cancer Risk Stratification in the Mammography Screening Population.
- Conley CC, Niell BL, Augusto BM, McIntyre M, Roetzheim R, Funaro K, Vadaparampil ST.
- J Am Coll Radiol. 2020 Mar 27. pii: S1546-1440(20)30240-4. doi: 10.1016/j.jacr.2020.02.019. [Epub ahead of print]
- PMID: 32229274
- PubMed abstract
- Source abstract
Press: Mailed Notices of High Breast Cancer Risk Do Not Often Translate Into Behavior Changes. (Medscape/Reuters)
-
- Hormone Replacement Therapy Prescription After Premature Surgical Menopause.
- Garg N, Behbehani S, Kosiorek H, Wasson M.
- J Minim Invasive Gynecol. 2020 Mar 12. pii: S1553-4650(20)30124-2. doi: 10.1016/j.jmig.2020.03.002. [Epub ahead of print]
- PMID: 32173578
- PubMed abstract
- Source abstract
-
- Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutations.
- Haque R, Skates SJ, Armstrong MA, Lentz SE, Anderson M, Jiang W, Alvarado MM, Chillemi G, Shaw SF, Kushi LH, Powell CB.
- Gynecol Oncol. 2020 Mar 4. pii: S0090-8258(20)30164-5. doi: 10.1016/j.ygyno.2020.02.027. [Epub ahead of print]
- PMID: 32145911
- PubMed abstract
- Source abstract
-
- Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
- Mills KA, Joshi TV, West L, Kuznicki M, Kent L, Hokenstad AN, Cripe JC, Woolfolk C, Senter L, Bakkum-Gamez JN, Wenham RM, Cohn DE, Bae-Jump V, Thaker PH.
- Gynecol Oncol. 2020 Mar 3. pii: S0090-8258(20)30179-7. doi: 10.1016/j.ygyno.2020.02.033. [Epub ahead of print]
- PMID: 32143914
- PubMed abstract
- Source abstract
-
- Factors that impact risk management decisions among women with pathogenic variants in moderate penetrance genes associated with hereditary breast cancer.
- Napoli M, Lewis J, Hopper J, Widmeyer K.
- J Genet Couns. 2020 Feb 3. doi: 10.1002/jgc4.1220. [Epub ahead of print]
- PMID: 32012395
- PubMed abstract
- Source abstract
-
- Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program.
- Hao J, Hassen D, Manickam K, Murray MF, Hartzel DN, Hu Y, Liu K, Rahm AK, Williams MS, Lazzeri A, Buchanan A, Sturm A, Snyder SR.
- J Pers Med. 2020 Feb 3;10(1). pii: E7. doi: 10.3390/jpm10010007.
- PMID: 32028596
- PubMed abstract
- Source abstract
-
- Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants.
- Hudson L, Gower N, Lenarcic S, Trufan SJ, White RL Jr.
- Ann Surg Oncol. 2020 Jan 23. doi: 10.1245/s10434-019-08191-0. [Epub ahead of print]
- PMID: 31974710
- PubMed abstract
- Source abstract
-
- Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
- Frey MK, Kahn RM, Chapman-Davis E, Tubito F, Pires , Christos P, Anderson S, Mukherjee S, Jordan B, Blank , Caputo TA, Sharaf , Offit K, Holcomb K, Lipkin S.
- J Clin Oncol. 2020 Jan 10:JCO1902005. doi: 10.1200/JCO.19.02005. [Epub ahead of print]
- PMID: 31922918
- PubMed abstract
- Source abstract
-
- Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
- Tynan M, Peshkin BN, Isaacs C, Willey S, Valdimarsdottir HB, Nusbaum R, Hooker G, O'Neill SC, Jandorf L, Kelly SP, Heinzmann J, Kelleher S, Poggi E, Schwartz MD.
- Breast Cancer Res Treat. 2020 Jan 1. doi: 10.1007/s10549-019-05515-2. [Epub ahead of print]
- PMID: 31894446
- PubMed abstract
- Source abstract
-
- Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing Behaviors.
- Samimi G, Heckman-Stoddard BM, Holmberg C, Tennant B, Sheppard BB, Coa KI, Kay SS, Ford LG, Szabo E, Minasian LM.
- Am J Med. 2019 Dec 17. pii: S0002-9343(19)31095-2. doi: 10.1016/j.amjmed.2019.11.017. [Epub ahead of print]
- PMID: 31862335
- PubMed abstract
- Source abstract
-
- Increased Overall Mortality Even after Risk Reducing Surgery for BRCA-Positive Women in Western Sweden.
- Öfverholm A, Einbeigi Z, Wigermo A, Holmberg E, Karsson P.
- Genes (Basel). 2019 Dec 16;10(12). pii: E1046. doi: 10.3390/genes10121046.
- PMID: 31888263
- PubMed abstract
- Source abstract
-
- Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication.
- Evans DG, Edwards M, Duffy SW; Cancer Genetics Group clinical leads, Tischkowitz M.
- Br J Cancer. 2019 Nov 25. doi: 10.1038/s41416-019-0631-2. [Epub ahead of print]
- PMID: 31761901
- PubMed abstract
- Source abstract
-
- Counseling young women with early breast cancer on fertility preservation.
- Ter Welle-Butalid MEE, Vriens IJHI, Derhaag JGJ, Leter EME, de Die-Smulders CEC, Smidt MM, van Golde RJTR, Tjan-Heijnen VCGV.
- J Assist Reprod Genet. 2019 Nov 23. doi: 10.1007/s10815-019-01615-6. [Epub ahead of print]
- PMID: 31760547
- PubMed abstract
-
- Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
- Vysotskaia V, Kaseniit KE, Bucheit L, Ready K, Price K, Johansen Taber K.
- Cancer. 2019 Nov 4. doi: 10.1002/cncr.32572. [Epub ahead of print]
- PMID: 31682005
- PubMed abstract
-
- Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
- Conley CC, Kasting ML, Augusto BM, Garcia JD, Cragun D, Gonzalez BD, Kim J, Ashing KT, Knott CL, Hughes-Halbert C, Pal T, Vadaparampil ST.
- Ann Surg Oncol. 2019 Nov 1. doi: 10.1245/s10434-019-07982-9. [Epub ahead of print]
- PMID: 31677107
- PubMed abstract
- Source abstract
-
- Outcomes of women at high familial risk for breast cancer: An 8-year single-center experience.
- Lammert J, Skandarajah AR, Shackleton K, Calder P, Thomas S, Lindeman GJ, Mann GB.
- Asia Pac J Clin Oncol. 2019 Oct 28. doi: 10.1111/ajco.13274. [Epub ahead of print]
- PMID: 31657879
- PubMed abstract
- Source abstract
-
- All For BRCA, BRCA For All?
- Resta R.
- The DNA Exchange. 2019 Oct 7.
- Blog post
- Free Full Text
-
- A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.
- Gronwald J, Lubinski J, Huzarski T, Cybulski C, Menkiszak J, Siołek M, Stawicka M, Sun P, Kim S, Kotsopoulos J, Narod SA.
- Gynecol Oncol. 2019 Sep 6. pii: S0090-8258(19)31486-6. doi: 10.1016/j.ygyno.2019.08.034. [Epub ahead of print]
- PMID: 31500890
- PubMed abstract
- Source abstract
-
- Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome.
- McGarragle KM, Aronson M, Semotiuk K, Holter S, Hare CJ, Ferguson SE, Cohen Z, Hart TL.
- Hered Cancer Clin Pract. 2019 Aug 13;17:24. doi: 10.1186/s13053-019-0123-7. eCollection 2019.
- PMID: 31423292
- PubMed abstract
-
- Participation in a Novel Trial Assessing Prophylactic Breast Irradiation: The Importance of Input from the Radiation Oncologist.
- Evron E, Goldberg H, Ben-David MA, Corn BW.
- Int J Radiat Oncol Biol Phys. 2019 Aug 10. pii: S0360-3016(19)33636-3. doi: 10.1016/j.ijrobp.2019.08.004. [Epub ahead of print]
- PMID: 31408668
- PubMed abstract
- Source abstract
-
- Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
- Terkelsen T, Rønning H, Skytte AB.
- Acta Oncol. 2019 Aug 5:1-6. doi: 10.1080/0284186X.2019.1648860. [Epub ahead of print]
- PMID: 31379231
- PubMed abstract
- Source abstract
-
- Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.
- van den Broek AJ, Schmidt MK, van 't Veer LJ, Oldenburg HSA, Rutgers EJ, Russell NS, Smit VTHBM, Voogd AC, Koppert LB, Siesling S, Jobsen JJ, Westenend PJ, van Leeuwen FE, Tollenaar RAEM.
- Ann Surg. 2019 Aug;270(2):364-372. doi: 10.1097/SLA.0000000000002804.
- PMID: 29727326
- PubMed abstract
- Source abstract
-
- A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre.
- Petelin L, Hossack L, Mitchell G, Liew D, Trainer AH, James PA.
- Value Health. 2019 Aug;22(8):854-862. doi: 10.1016/j.jval.2019.03.008. Epub 2019 May 17.
- PMID: 31426925
- PubMed abstract
- Source abstract
-
- Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
- Chang J, Seng S, Yoo J, Equivel P, Lum SS.
- Ann Surg Oncol. 2019 Jul 24. doi: 10.1245/s10434-019-07595-2. [Epub ahead of print]
- PMID: 31342386
- PubMed abstract
- Source abstract
-
- Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers.
- Nagura N, Hayashi N, Takei J, Yoshida A, Ochi T, Iwahira Y, Yamauchi H.
- Breast Cancer. 2019 Jul 10. doi: 10.1007/s12282-019-00995-y. [Epub ahead of print]
- PMID: 31292927
- PubMed abstract
- Source abstract
-
- Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancers.
- Swink A, Nair A, Hoof P, Matthews A, Burden C, Johnson K, Blum JL.
- Proc (Bayl Univ Med Cent). 2019 Jun 11;32(3):340-344. doi: 10.1080/08998280.2019.1612702. eCollection 2019 Jul.
- PMID: 31384183
- PubMed abstract
- Source abstract
-
- Concurrent hysterectomy at the tine of risk-reducing surgery for patients with BRCA mutations.
- Gordhandas S, Ruiz MP, Talukdar N, Holcomb KM, Freya MK, Chapman-Davis E, Kahn RM.
- Gynecol Oncol. 2019 Jun;153(3):e12-e13. doi: 10.1016/j.ygyno.2019.03.134.
-
- Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations.
- Salyer C, Kobelka C, Barrie A, Weintraub MR, Powell CB.
- Gynecol Oncol. 2019 May 31. pii: S0090-8258(19)31261-2. doi: 10.1016/j.ygyno.2019.05.017. [Epub ahead of print]
- PMID: 31160070
- PubMed abstract
- Source abstract
-
- Challenges in Managing Patients with Hereditary Cancer at Gynecological Services.
- Ueda M, Tsubamoto H, Kashima-Morii M, Torii Y, Kamihigashi M, Wakimoto Y, Nakagomi N, Hashimoto-Tamaoki T, Sawai H, Shibahara H.
- Obstet Gynecol Int. 2019 May 27;2019:4365754. doi: 10.1155/2019/4365754. eCollection 2019.
- PMID: 31263500
- PubMed abstract
-
- NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.
- Maani N, Westergard S, Yang J, Scaranelo AM, Telesca S, Thain E, Schachter NF, McCuaig JM, Kim RH.
- Cancers (Basel). 2019 May 22;11(5). pii: E707. doi: 10.3390/cancers11050707.
- PMID: 31121919
- PubMed abstract
- Source abstract
-
- Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review.
- Lee SI, Patel M, Dutton B, Weng S, Luveta J, Qureshi N.
- J Community Genet. 2019 May 6. doi: 10.1007/s12687-019-00419-6. [Epub ahead of print]
- PMID: 31062229
- PubMed abstract
- Source abstract
-
- Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?
- Roch AM, Schneider J, Carr RA, Lancaster WP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM, Ceppa EP.
- J Surg Oncol. 2019 May;119(6):777-783. doi: 10.1002/jso.25376. Epub 2019 Jan 12.
- PMID: 30636051
- PubMed abstract
-
- Hereditary Breast Cancer Risk Analysis in Uninsured Mexican-Origin Women Living in the U.S.-Mexico Border Region.
- Salinas JJ, Roy R, Dwivedi AK, Shokar NK.
- Hisp Health Care Int. 2019 Apr 12:1540415319837850. doi: 10.1177/1540415319837850. [Epub ahead of print]
- PMID: 30974976
- PubMed abstract
- Source abstract
-
- International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.
- Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.
- Br J Cancer. 2019 Apr 11. doi: 10.1038/s41416-019-0446-1. [Epub ahead of print]
- PMID: 30971774
- PubMed abstract
- Source abstract
Editorial:
Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
- PMID: 31171836
- PubMed abstract
- Free Full Text
-
- Predictive Power of PEN-3 Model Constructs in Breast Cancer Screening Behaviors among Teachers: A Cross- Sectional Study in Central Iran.
- Moghaddam ES, Shahnazi H, Hassanzadeh A.
- Eur J Breast Health. 2019 Apr 1;15(2):105-110. doi: 10.5152/ejbh.2019.4417. eCollection 2019 Apr.
- PMID: 31001612
- PubMed abstract
- Source abstract
-
- Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy.
- Grobmyer SR, Pederson HJ, Valente SA, Al-Hilli Z, Radford D, Djohan R, Yetman R, Eng C, Crowe JP.
- BJS Open. 2018 Nov 26;3(2):169-173. doi: 10.1002/bjs5.50117. eCollection 2019 Apr.
- PMID: 30957063
- PubMed abstract
- Source abstract
-
- Yield of surveillance magnetic resonance imaging after bilateral mastectomy and reconstruction: a retrospective cohort study.
- Golan O, Amitai Y, Barnea Y, Menes TS.
- Breast Cancer Res Treat. 2019 Apr;174(2):463-468. doi: 10.1007/s10549-018-05077-9. Epub 2018 Dec 3.
- PMID: 30511241
- PubMed abstract
- Source abstract
-
- A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
- Donenberg T, George S, Ali J, Bravo G, Hernandez K, Sookar N, Ashing KT, Narod SA, Akbari MR, Hurley J.
- Breast Cancer Res Treat. 2019 Apr;174(2):469-477. doi: 10.1007/s10549-018-5045-y. Epub 2018 Dec 4.
- PMID: 30515680
- PubMed abstract
- Source abstract
-
- Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility.
- Rowley SM, Mascarenhas L, Devereux L, Li N, Amarasinghe KC, Zethoven M, Lee JEA, Lewis A, Morgan JA, Limb S, Young MA, James PA, Trainer AH, Campbell IG.
- Genet Med. 2019 Apr;21(4):913-922. doi: 10.1038/s41436-018-0277-0. Epub 2018 Sep 26.
- PMID: 30254378
- PubMed abstract
- Source abstract
-
- Risk perception and screening behavior of Filipino women at risk for breast cancer: implications for cancer genetic counseling.
- Lagarde JBB, Laurino MY, San Juan MD, Cauyan JML, Tumulak MJR, Ventura ER.
- J Community Genet. 2019 Apr;10(2):281-289. doi: 10.1007/s12687-018-0391-3. Epub 2018 Sep 27.
- PMID: 30259342
- PubMed abstract
- Source abstract
-
- Gaps in information about breast cancer risk and prevention impact African American women.
- [No author given]
- FORCE. XRAYS. 2019 Mar 14.
- Research news
- Free Full Text
Original research:
Layers of information: interacting constraints on breast cancer risk-management by high-risk African American women.
- PMID: 30589360
- PubMed abstract
- Source abstract
-
- Trends in Breast MRI Use Among Women with BRCA Mutations: A National Claims Analysis 2006–2016.
- Wernli KJ, Callaway KA, Henderson LM, Kerlikowske K, Lee JM, Ross-Degnan D, Wallace JK, Wharam JF, Zhang F, Stout NK.
- Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):624. doi: 10.1158/1055-9965.EPI-19-0079.
-
- The influence of BRCA variants of unknown significance on cancer risk management decision-making.
- Chern JY, Lee SS, Frey MK, Lee J, Blank SV.
- J Gynecol Oncol. 2019 Feb 27. doi: 10.3802/jgo.2019.30.e60. [Epub ahead of print]
- PMID: 31074248
- PubMed abstract
- Source abstract
Editorial:
Clinical significance of variants of unknown significances in BRCA genes.
- PMID: 31074233
- PubMed abstract
- Free Full Text
-
- Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE).
- Henry DA, Lee MC, Almanza D, Ahmed KA, Sun W, Boulware DC, Laronga C.
- Breast Cancer Res Treat. 2019 Feb;174(1):39-45. doi: 10.1007/s10549-018-5057-7. Epub 2018 Nov 24.
- PMID: 30474778
- PubMed abstract
- Source abstract
-
- Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.
- Hanley GE, McAlpine JN, Cheifetz R, Schrader KA, McCullum M, Huntsman D.
- Curr Oncol. 2019 Feb;26(1):e17-e23. doi: 10.3747/co.26.4068. Epub 2019 Feb 1.
- PMID: 30853805
- PubMed abstract
- Source abstract
-
- High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
- Nilsson MP, Nilsson ED, Borg Å, Brandberg Y, Silfverberg B, Loman N.
- Breast Cancer Res Treat. 2019 Jan;173(2):313-318. doi: 10.1007/s10549-018-5000-y. Epub 2018 Oct 11.
- PMID: 30311024
- PubMed abstract
-
- Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers.
- Lee EG, Kang HJ, Lim MC, Park B, Park SJ, Jung SY, Lee S, Kang HS, Park SY, Park B, Joo J, Han JH, Kong SY, Lee ES.
- Cancer Res Treat. 2019 Jan;51(1):280-288. doi: 10.4143/crt.2018.079. Epub 2018 May 4.
- PMID: 29747489
- PubMed abstract
-
- Layers of information: interacting constraints on breast cancer risk-management by high-risk African American women.
- Padamsee TJ, Meadows R, Hils M.
- Ethn Health. 2018 Dec 27:1-24. doi: 10.1080/13557858.2018.1562053. [Epub ahead of print]
- PMID: 30589360
- PubMed abstract
- Source abstract
Research news: Gaps in information about breast cancer risk and prevention impact African American women (FORCE. XRAYS.)
-
- Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer.
- Narod SA.
- JAMA Oncol. 2018 Dec 1;4(12):1787-1788. doi: 10.1001/jamaoncol.2018.4931.
- PMID: 30383137
- PubMed abstract
- Source abstract
Original Research:
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
- PMID: 29801090
- PubMed abstract
- Source abstract
Letter, reply:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer—Reply
- PMID: 30383131
- PubMed abstract
- Source abstract
-
- Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers.
- D'Alonzo M, Piva E, Pecchio S, Liberale V, Modaffari P, Ponzone R, Biglia N.
- Clin Breast Cancer. 2018 Dec;18(6):e1361-e1366. doi: 10.1016/j.clbc.2018.07.015. Epub 2018 Jul 26.
- PMID: 30122348
- PubMed abstract
- Source abstract
-
- Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.
- Mor P, Brennenstuhl S, Metcalfe KA.
- J Genet Couns. 2018 Dec;27(6):1386-1394. doi: 10.1007/s10897-018-0264-2. Epub 2018 Jun 1.
- PMID: 29858758
- PubMed abstract
- Source abstract
-
- Pathogenic Variants in Less Familiar Cancer Susceptibility Genes: What Happens After Genetic Testing?
- Hall ET, Parikh D, Caswell-Jin JL, Gupta T, Mills MA, Kingham KE, Koff R, Ford JM, Kurian AW.
- JCO Precis Oncol. [2018 Nov 8];2:1-10. doi: 10.1200/PO.18.00167.
- PMID: 35135157
- PubMed abstract
- Source abstract
-
- Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
- Nielsen SM, Eccles DM, Romero IL, Al-Mulla F, Balmaña J, Biancolella M, Bslok R, Caligo MA, Calvello M, Capone GL, Cavalli P, Chan TLC, Claes KBM, Cortesi L, Couch FJ, de la Hoya M, De Toffol S, Diez O, Domchek SM, Eeles R, Efremidis A, Fostira F, Goldgar D, Hadjisavvas A, Hansen TVO, Hirasawa A, Houdayer C, Kleiblova P, Krieger S, Lázaro C, Loizidou M, Manoukian S, Mensenkamp AR, Moghadasi S, Monteiro AN, Mori L, Morrow A, Naldi N, Nielsen HR, Olopade OI, Pachter NS, Palmero EI, Pedersen IS, Piane M, Puzzo M, Robson M, Rossing M, Sini MC, Solano A, Soukupova J, Tedaldi G, Teixeira M, Thomassen M, Tibiletti MG, Toland A, Törngren T, Vaccari E, Varesco L, Vega A, Wallis Y, Wappenschmidt B, Weitzel J, Spurdle AB, De Nicolo A, Gómez-García EB.
- JCO Precis Oncol. 2018;2. doi: 10.1200/PO.18.00091. Epub 2018 Oct 26.
- PMID: 31517176
- PubMed abstract
-
- Comparison of gynecologic cancer risk factors, incidence and mortality trends between South Korea and Israel, 1999-2013.
- Michaan N, Park SY, Won YJ, Lim MC.
- Jpn J Clin Oncol. 2018 Oct 1;48(10):884-891. doi: 10.1093/jjco/hyy111.
- PMID: 30113642
- PubMed abstract
- Source abstract
-
- Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience.
- Courtney E, Chin XW, Yuen J, Li ST, Chen Y, Allen JC Jr, Tan V, Lim GH, Ngeow J.
- Fam Cancer. 2018 Oct;17(4):621-626. doi: 10.1007/s10689-018-0071-9.
- PMID: 29368260
- PubMed abstract
- Source abstract
-
- Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.
- Petelin L, Trainer AH, Mitchell G, Liew D, James PA.
- Genet Med. 2018 Oct;20(10):1145-1156. doi: 10.1038/gim.2017.255. Epub 2018 Jan 11.
- PMID: 29323669
- PubMed abstract
- Source abstract
-
- Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.
- Dossa F, Cusimano MC, Sutradhar R, Metcalfe K, Little T, Lerner-Ellis J, Eisen A, Meschino WS, Baxter NN.
- BMJ Open. 2018 Sep 4;8(9):e025317. doi: 10.1136/bmjopen-2018-025317.
- PMID: 30181190
- PubMed abstract
-
- Factors associated with breast MRI use among women with a family history of breast cancer.
- White MC, Soman A, Weinberg CR, Rodriguez JL, Sabatino SA, Peipins LA, DeRoo L, Nichols HB, Hodgson ME, Sandler DP.
- Breast J. 2018 Sep;24(5):764-771. doi: 10.1111/tbj.13063. Epub 2018 May 20.
- PMID: 29781100
- PubMed abstract
- Source abstract
-
- Response to "A Psychological Perspective on Factors Predicting Prophylactic Salpingo-Oophorectomy in a Sample of Italian Women from the General Population. Results from a Hypothetical Study in the Context of BRCA Mutations".
- Cox DM.
- J Genet Couns. 2018 Sep;27(5):1312-1313. doi: 10.1007/s10897-018-0280-2. Epub 2018 Jul 21.
- PMID: 30032367
- PubMed abstract
- Source abstract
A Psychological Perspective on Factors Predicting Prophylactic Salpingo-Oophorectomy in a Sample of Italian Women from the General Population. Results from a Hypothetical Study in the Context of BRCA Mutations.
- PMID: 28337671
- PubMed abstract
- Source abstract
Letter, Reply:
Letter to the Editor: Response to Cox (2018).
- PMID: 30056477
- PubMed abstract
- Source abstract
-
- Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
- Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ.
- JAMA Oncol. 2018 Aug 1;4(8):1066-1072. doi: 10.1001/jamaoncol.2018.0644.
- PMID: 29801090
- PubMed abstract
- Source abstract
Press: Multigene Sequencing Rapidly Replacing BRCA Tests. (Medscape Oncology)
Letter, Comment:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer.
- PMID: 30383137
- PubMed abstract
- Source abstract
Letter, Reply:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer-Reply.
- PMID: 30383131
- PubMed abstract
- Source abstract
-
- Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
- McVeigh TP, Wiggins J, Ward S, Kemp Z, George AJ.
- Clin Breast Cancer. 2018 Aug;18(4):282-288. doi: 10.1016/j.clbc.2017.10.015. Epub 2017 Oct 28.
- PMID: 29191429
- PubMed abstract
- Source abstract
-
- Inadequate Rates of BRCA Testing with its Negative Consequences for Women with Epithelial Ovarian Cancer and their Families: an Overview of the Literature.
- Hoskins PJ.
- Clin Oncol (R Coll Radiol). 2018 Aug;30(8):472-483. doi: 10.1016/j.clon.2018.04.004. Epub 2018 May 5.
- PMID: 29735311
- PubMed abstract
- Source abstract
-
- Impact of preoperative BRCA1/2 testing on surgical decision making in patients with newly diagnosed breast cancer.
- Yadav S, Jinna S, Pereira-Rodrigues O, Reeves A, Campian S, Sufka A, Zakalik D.
- Breast J. 2018 Jul;24(4):541-548. doi: 10.1111/tbj.13007. Epub 2018 Mar 2.
- PMID: 29498445
- PubMed abstract
- Source abstract
-
- Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
- Long J, Evans TG, Bailey D, Lewis MH, Gower-Thomas K, Murray A.
- Breast J. 2018 Jul;24(4):580-585. doi: 10.1111/tbj.12978. Epub 2017 Dec 29.
- PMID: 29286205
- PubMed abstract
- Source abstract
-
- Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.
- Kearton S, Wills K, Bunting M, Blomfield P, James PA, Burke J.
- Fam Cancer. 2018 Jul;17(3):333-344. doi: 10.1007/s10689-017-0047-1.
- PMID: 29039136
- PubMed abstract
- Source abstract
-
- Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer.
- Franc BL, Copeland TP, Thombley R, Park M, Marafino B, Dean ML, Boscardin WJ, Rugo HS, Seidenwurm D, Sharma B, Johnston SR, Dudley RA.
- J Natl Compr Canc Netw. 2018 Jul;16(7):829-837. doi: 10.6004/jnccn.2018.7024.
- PMID: 30006425
- PubMed abstract
- Source abstract
-
- Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia.
- Lim KK, Yoon SY, Mohd Taib NA, Shabaruddin FH, Dahlui M, Woo YL, Thong MK, Teo SH, Chaiyakunapruk N.
- Appl Health Econ Health Policy. 2018 Jun;16(3):395-406. doi: 10.1007/s40258-018-0384-8.
- PMID: 29572724
- PubMed abstract
- Source abstract
-
- Effects of Cancer Genetic Panel Testing on at-Risk Individuals.
- Frost AS, Toaff M, Biagi T, Stark E, McHenry A, Kaltman R.
- Obstet Gynecol. 2018 Jun;131(6):1103-1110. doi: 10.1097/AOG.0000000000002531.
- PMID: 29742654
- PubMed abstract
- Source abstract
-
- Risk management decisions in women with BRCA1 and BRCA2 mutations.
- Morgan R, Brown A, Hamman KJ, Sampson J, Naik A, Massimino K.
- Am J Surg. 2018 May;215(5):899-903. doi: 10.1016/j.amjsurg.2018.02.010. Epub 2018 Feb 13.
- PMID: 29499861
- PubMed abstract
- Source abstract
-
- Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants.
- Buchanan AH, Manickam K, Meyer MN, Wagner JK, Hallquist MLG, Williams JL, Rahm AK, Williams MS, Chen ZE, Shah CK, Garg TK, Lazzeri AL, Schwartz MLB, Lindbuchler DM, Fan AL, Leeming R, Servano PO 3rd, Smith AL, Vogel VG, Abul-Husn NS, Dewey FE, Lebo MS, Mason-Suares HM, Ritchie MD, Davis FD, Carey DJ, Feinberg DT, Faucett WA, Ledbetter DH, Murray MF.
- Genet Med. [2018 May;]20(5):554-558. doi: 10.1038/gim.2017.145. Epub 2017 Oct 26.
- PMID: 29261187
- PubMed abstract
-
- Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
- Barrington DA, Champion ML, Boitano TKL, Walters-Haygood CL, Farmer MB, Alvarez RD, Estes JM, Leath CA 3rd.
- Gynecol Oncol. 2018 May;149(2):337-340. doi: 10.1016/j.ygyno.2018.02.014. Epub 2018 Mar 2.
- PMID: 29486991
- PubMed abstract
- Source abstract
-
- Results of surveillance in individuals at high-risk of pancreatic cancer: A systematic review and meta-analysis.
- Signoretti M, Bruno MJ, Zerboni G, Poley JW, Delle Fave G, Capurso G.
- United European Gastroenterol J. 2018 May;6(4):489-499. doi: 10.1177/2050640617752182. Epub 2018 Jan 8.
- PMID: 29881603
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- An iPhone Application Intervention to Promote Surveillance Among Women with a BRCA Mutation: Pre-intervention Data.
- Cohen SA, Scherr CL, Nixon DM.
- J Genet Couns. 2018 Apr;27(2):446-456. doi: 10.1007/s10897-018-0224-x. Epub 2018 Feb 10.
- PMID: 29429041
- PubMed abstract
- Source abstract
-
- Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
- Arai M, Yokoyama S, Watanabe C, Yoshida R, Kita M, Okawa M, Sakurai A, Sekine M, Yotsumoto J, Nomura H, Akama Y, Inuzuka M, Nomizu T, Enomoto T, Nakamura S.
- J Hum Genet. 2018 Apr;63(4):447-457. doi: 10.1038/s10038-017-0355-1. Epub 2017 Nov 8.
- PMID: 29176636
- PubMed abstract
-
- Breast Cancer Screening Behaviors of First Degree Relatives of Women Receiving Breast Cancer Treatment and the Affecting Factors.
- Kırca N, Tuzcu A, Gözüm S.
- Eur J Breast Health. 2018 Jan 1;14(1):23-28. doi: 10.5152/ejbh.2017.3272. eCollection 2018 Jan.
- PMID: 29322115
- PubMed abstract
- Source abstract
-
- A single visit multidisciplinary model for managing patients with mutations in moderate and high-risk genes in a community practice setting.
- O'Leary MP, Goldner BS, Abboy S, Mercado PD, Plurad HY.
- Fam Cancer. 2018 Jan;17(1):175-178. doi: 10.1007/s10689-017-0010-1.
- PMID: 28600699
- PubMed abstract
- Source abstract
-
- Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.
- Laitman Y, Feldman DM, Sklair-Levy M, Yosepovich A, Barshack-Nakar I, Brodsky M, Halshtok O, Shalmon A, Gotlieb M, Friedman E.
- Clin Breast Cancer. 2017 Dec 11. pii: S1526-8209(17)30559-1. doi: 10.1016/j.clbc.2017.12.005. [Epub ahead of print]
- PMID: 29292184
- PubMed abstract
- Source abstract
-
- No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families.
- Guedaoura S, Pelletier S, Foulkes WD, Hamet P, Simard J, Wong N, El Haffaf Z, Chiquette J, Dorval M.
- Curr Oncol. 2017 Dec;24(6):352-359. doi: 10.3747/co.24.3759. Epub 2017 Dec 20.
- PMID: 29270046
- PubMed abstract
- Source abstract
-
- Identification and management of familial breast cancer in Austria.
- Singer CF, Tan YY, Rappaport C.
- Horm Mol Biol Clin Investig. 2017 Nov 30;32(2). pii: /j/hmbci.2017.32.issue-2/hmbci-2017-0025/hmbci-2017-0025.xml. doi: 10.1515/hmbci-2017-0025.
- PMID: 29190211
- PubMed abstract
- Source abstract
-
- Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version. Psychosocial Issues in Inherited Breast and Ovarian Cancer Syndromes. Psychosocial Aspects of Cancer Risk Management for Hereditary Breast and Ovarian Cancer. Uptake of cancer risk management options.
- PDQ Cancer Genetics Editorial Board.
- PDQ Cancer Information Summaries [Internet]. Bethesda, MD: National Cancer Institute. Updated 2017 Nov 30. Accessed 2017 Dec 8.
- PMID: 26389210
- PubMed abstract
- Section link
-
- Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version. Psychosocial Issues in Inherited Breast and Ovarian Cancer Syndromes. Behavioral Outcomes.
- PDQ Cancer Genetics Editorial Board.
- PDQ Cancer Information Summaries [Internet]. Bethesda, MD: National Cancer Institute. Updated 2017 Nov 30. Accessed 2017 Dec 8.
- PMID: 26389210
- PubMed abstract
- Section link
-
- Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
- Wahner Hendrickson AE, Bakkum-Gamez JN, J Couch F, Ghosh K, Boughey JC.
- Ann Surg Oncol. 2017 Oct;24(11):3107-3109. doi: 10.1245/s10434-017-5999-8. Epub 2017 Jul 20.
- PMID: 28730286
- PubMed abstract
- Editorial
- Free Full Text
Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
- PMID: 28699130
- PubMed abstract
- Source abstract
-
- Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
- Gamble C, Havrilesky LJ, Myers ER, Chino JP, Hollenbeck S, Plichta JK, Kelly Marcom P, Shelley Hwang E, Kauff ND, Greenup RA.
- Ann Surg Oncol. 2017 Oct;24(11):3116-3123. doi: 10.1245/s10434-017-5995-z. Epub 2017 Jul 11.
- PMID: 28699130
- PubMed abstract
- Source abstract
Editorial:
Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
- PMID: 28730286
- PubMed abstract
- Free Full Text
-
- Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.
- Gilbert E, Zabor EC, Stempel M, Mangino D, Heerdt A, Pilewskie M.
- Ann Surg Oncol. 2017 Oct;24(10):3048-3054. doi: 10.1245/s10434-017-5976-2. Epub 2017 Aug 1.
- PMID: 28766223
- PubMed abstract
- Source abstract
-
- Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
- Welsh JL, Hoskin TL, Day CN, Thomas AS, Cogswell JA, Couch FJ, Boughey JC.
- Ann Surg Oncol. 2017 Oct;24(10):3067-3072. doi: 10.1245/s10434-017-5959-3. Epub 2017 Aug 1.
- PMID: 28766224
- PubMed abstract
- Source abstract
-
- Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer.
- Hermel DJ, Wood ME, Chun J, Rounds T, Sands M, Schwartz S, Schnabel FR.
- Clin Breast Cancer. 2017 Oct;17(6):427-432. doi: 10.1016/j.clbc.2017.04.005. Epub 2017 Apr 14.
- PMID: 28539235
- PubMed abstract
- Source abstract
-
- A Psychological Perspective on Factors Predicting Prophylactic Salpingo-Oophorectomy in a Sample of Italian Women from the General Population. Results from a Hypothetical Study in the Context of BRCA Mutations.
- Gavaruzzi T, Tasso A, Franiuk M, Varesco L, Lotto L.
- J Genet Couns. 2017 Oct;26(5):1144-1152. doi: 10.1007/s10897-017-0093-8. Epub 2017 Mar 23.
- PMID: 28337671
- PubMed abstract
- Source abstract
Letter:
Response to "A Psychological Perspective on Factors Predicting Prophylactic Salpingo-Oophorectomy in a Sample of Italian Women from the General Population. Results from a Hypothetical Study in the Context of BRCA Mutations".
- PMID: 30032367
- PubMed abstract
- Source abstract
Letter, Reply:
Letter to the Editor: Response to Cox (2018).
- PMID: 30056477
- PubMed abstract
- Source abstract
-
- BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.
- Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ.
- MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.
- PMID: 28880857
- PubMed abstract
-
- Screening Mammography for Women in Their 40s: The Potential Impact of the American Cancer Society and U.S. Preventive Services Task Force Breast Cancer Screening Recommendations.
- Pitman JA, McGinty GB, Soman RR, Drotman MB, Reichman MB, Arleo EK.
- AJR Am J Roentgenol. 2017 Sep;209(3):697-702. doi: 10.2214/AJR.16.17759. Epub 2017 May 15.
- PMID: 28504572
- PubMed abstract
- Source abstract
-
- Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.
- Liede A, Mansfield CA, Metcalfe KA, Price MA; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Snyder C, Lynch HT, Friedman S, Amelio J, Posner J, Narod SA, Lindeman GJ, Evans DG.
- Breast Cancer Res Treat. 2017 Sep;165(2):433-444. doi: 10.1007/s10549-017-4332-3. Epub 2017 Jun 17.
- PMID: 28624978
- PubMed abstract
-
- Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.
- Interrante MK, Segal H, Peshkin BN, Valdimarsdottir HB, Nusbaum R, Similuk M, DeMarco T, Hooker G, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Heinzmann J, Kinney AY, Schwartz MD.
- JNCI Cancer Spectr. 2017 Sep;1(1):pkx002. doi: 10.1093/jncics/pkx002. Epub 2017 Sep 22.
- PMID: 31304457
- PubMed abstract
-
- Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
- Cragun D, Weidner A, Lewis C, Bonner D, Kim J, Vadaparampil ST, Pal T.
- Cancer. 2017 Jul 1;123(13):2497-2505. doi: 10.1002/cncr.30621. Epub 2017 Feb 9.
- PMID: 28182268
- PubMed abstract
- Source abstract
-
- Practice Patterns of Hereditary Ovarian Cancer Management in Korea.
- Choi MC, Lim MC, Lee M, Kim MK, Suh DH, Song YJ, Kim TJ, Chang SJ, Kim JW.
- Int J Gynecol Cancer. 2017 Jun;27(5):895-899. doi: 10.1097/IGC.0000000000000964.
- PMID: 28498247
- PubMed abstract
- Source abstract
-
- Influence of the Angelina Jolie Announcement and Insurance Reimbursement on Practice Patterns for Hereditary Breast Cancer.
- Lee J, Kim S, Kang E, Park S, Kim Z, Lee MH; Korean Breast Cancer Society.
- J Breast Cancer. 2017 Jun;20(2):203-207. doi: 10.4048/jbc.2017.20.2.203. Epub 2017 Jun 26.
- PMID: 28690658
- PubMed abstract
- Source abstract
-
- Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.
- Johns D, Agarwal J, Anderson L, Ying J, Kohlmann W.
- J Womens Health (Larchmt). 2017 Jun;26(6):702-706. doi: 10.1089/jwh.2016.5931. Epub 2016 Dec 6.
- PMID: 27922795
- PubMed abstract
- Source abstract
-
- Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks.
- Strigel RM, Rollenhagen J, Burnside ES, Elezaby M, Fowler AM, Kelcz F, Salkowski L, DeMartini WB.
- Acad Radiol. 2017 Apr;24(4):411-417. doi: 10.1016/j.acra.2016.10.014. Epub 2016 Dec 13.
- PMID: 27986508
- PubMed abstract
- Source abstract
-
- Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.
- Skandarajah AR, Thomas S, Shackleton K, Chin-Lenn L, Lindeman GJ, Mann GB.
- Breast. 2017 Apr;32:93-97. doi: 10.1016/j.breast.2017.01.002. Epub 2017 Jan 18.
- PMID: 28107734
- PubMed abstract
- Source abstract
-
- Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.
- Mai PL, Piedmonte M, Han PK, Moser RP, Walker JL, Rodriguez G, Boggess J, Rutherford TJ, Zivanovic O, Cohn DE, Thigpen JT, Wenham RM, Friedlander ML, Hamilton CA, Bakkum-Gamez J, Olawaiye AB, Hensley ML, Greene MH, Huang HQ, Wenzel L.
- Gynecol Oncol. 2017 Apr;145(1):122-129. doi: 10.1016/j.ygyno.2017.02.008. Epub 2017 Feb 10.
- PMID: 28190649
- PubMed abstract
- Source abstract
-
- The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use.
- Roberts MC, Dusetzina SB.
- J Community Genet. 2017 Apr;8(2):141-146. doi: 10.1007/s12687-017-0295-7. Epub 2017 Mar 15.
- PMID: 28299592
- PubMed abstract
- Source abstract
-
- Decision making for breast cancer prevention among women at elevated risk.
- Padamsee TJ, Wills CE, Yee LD, Paskett ED.
- Breast Cancer Res. 2017 Mar 24;19(1):34. doi: 10.1186/s13058-017-0826-5.
- PMID: 28340626
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.
- Buchanan AH, Voils CI, Schildkraut JM, Fine C, Horick NK, Marcom PK, Wiggins K, Skinner CS.
- J Genet Couns. 2017 Feb;26(1):79-92. doi: 10.1007/s10897-016-9981-6. Epub 2016 Jun 6.
- PMID: 27265406
- PubMed abstract
- Source abstract
-
- Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial.
- Desai S, Jena AB.
- BMJ. 2016 Dec 14;355:i6357. doi: 10.1136/bmj.i6357.
- PMID: 27974323
- PubMed abstract
Research News:
Angelina Jolie's mastectomy triggered sharp rise in gene testing.
- PMID: 27979800
- PubMed abstract
- Source abstract
Research News: Angelina Jolie spoke out on BRCA testing: Did genetic testing increase? (FORCE)
Blog post: "Angelina Jolie Effect”: What Should I Know About Hereditary Cancer and Testing? (NSGC Blog)
Research News: Were women foolish to follow Angelina Jolie into BRCA cancer gene testing? (STAT)
Research News: Jolie Effect: BRCA Tests Up but No Change in Mastectomy. (Medscape)
-
- A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.
- Yerushalmi R, Rizel S, Zoref D, Sharon E, Eitan R, Sabah G, Grubstein A, Rafson Y, Cohen M, Magen A, Birenboim I, Margel D, Ozlavo R, Sulkes A, Brenner B, Perry S.
- Isr Med Assoc J. 2016 Sep;18(9):549-552.
- PMID: 28471604
- PubMed abstract
- Source abstract
Editorial:
Handling Individuals with High Cancer Risk: One Size Doesn't Fit All.
- PMID: 28471608
- PubMed abstract
- Source abstract
-
- Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.
- Vetter L, Keller M, Bruckner T, Golatta M, Eismann S, Evers C, Dikow N, Sohn C, Heil J, Schott S.
- Breast Cancer Res Treat. 2016 Apr;156(2):289-99. doi: 10.1007/s10549-016-3748-5. Epub 2016 Mar 9.
- PMID: 26960712
- PubMed abstract
- Source abstract
-
- Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study.
- Podo F, Santoro F, Di Leo G, Manoukian S, de Giacomi C, Corcione S, Cortesi L, Carbonaro LA, Trimboli RM, Cilotti A, Preda L, Bonanni B, Pensabene M, Martincich L, Savarese A, Contegiacomo A, Sardanelli F.
- Clin Cancer Res. 2016 Feb 15;22(4):895-904. doi: 10.1158/1078-0432.CCR-15-0459. Epub 2015 Oct 26.
- PMID: 26503945
- PubMed abstract
- Source abstract
-
- Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations.
- Robinson LS, Hendrix A, Xie XJ, Yan J, Pirzadeh-Miller S, Pritzlaff M, Read P, Pass S, Euhus D, Ross TS.
- EBioMedicine. 2015 Oct 21;2(11):1827-33. doi: 10.1016/j.ebiom.2015.10.022. eCollection 2015.
- PMID: 26870808
- PubMed abstract
- Source abstract
Commentary
Differences in Uptake of Risk Reduction Strategies Among Underserved Populations.
- PMID: 26870783
- PubMed abstract
- Source abstract
-
- Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.
- Garcia C, Lyon L, Littell RD, Powell CB.
- Genet Med. 2014 Dec;16(12):896-902. doi: 10.1038/gim.2014.48. Epub 2014 May 22.
- PMID: 24854227
- PubMed abstract
- Source abstract
-
- Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history.
- Kwong A, Chu AT, Wu CT, Tse DM.
- Fam Cancer. 2014 Sep;13(3):423-30. doi: 10.1007/s10689-014-9706-7.
- PMID: 24623488
- PubMed abstract
- Source abstract
-
- Disclosure Pattern and Follow-Up After the Molecular Diagnosis of BRCA/CHEK2 Mutations.
- Kegelaers D, Merckx W, Odeurs P, van den Ende J, Blaumeiser B.
- J Genet Couns. 2014 Apr;23(2):254-61. doi: 10.1007/s10897-013-9656-5. Epub 2013 Oct 11.
- PMID: 24114282
- PubMed abstract
- Source abstract
-
- Risk management options elected by women after testing positive for a BRCA mutation.
- Garcia C, Wendt J, Lyon L, Jones J, Littell RD, Armstrong MA, Raine-Bennett T, Powell CB.
- Gynecol Oncol. 2014 Feb;132(2):428-33. doi: 10.1016/j.ygyno.2013.12.014. Epub 2013 Dec 16.
- PMID: 24355485
- PubMed abstract
- Source abstract
-
- The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers.
- Borreani C, Manoukian S, Bianchi E, Brunelli C, Peissel B, Caruso A, Morasso G, Pierotti M.
- Clin Genet. 2014 Jan;85(1):7-15. doi: 10.1111/cge.12298. Epub 2013 Nov 5.
- PMID: 24117034
- PubMed abstract
- Source abstract
-
- Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
- Pal T, Lee JH, Besharat A, Thompson Z, Monteiro A, Phelan C, Lancaster J, Metcalfe K, Sellers T, Vadaparampil S, Narod S.
- Clin Genet. 2014 Jan;85(1):49-53. doi: 10.1111/cge.12130. Epub 2013 Mar 21.
- PMID: 23438721
- PubMed abstract
- Source abstract
-
- Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria.
- Singer C, Muhr D, Rappaport C, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Pfeiler G, Berger A, Sun P, Narod S.
- Clin Genet. 2014 Jan;85(1):72-5. doi: 10.1111/cge.12216. Epub 2013 Jul 16.
- PMID: 23772696
- PubMed abstract
- Source abstract
-
- Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
- Collins IM, Milne RL, Weideman PC, McLachlan SA, Friedlander ML, Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer KC, Hopper JL, Phillips KA.
- Med J Aust. 2013 Nov 18;199(10):680-3.
- PMID: 24237098
- PubMed abstract
-
- Patterns of breast cancer surveillance and breast cancer detection in women with serous ovarian/tubal or peritoneal carcinomas who have had brca mutation testing.
- Daniel Paik, Farin Amersi, Alexandra Gangi, Catherine Dang, Beth Karlan, Ronald Leuchter, Andrew Li, Christine Walsh, B.J. Rimel, Ilana Cass.
- Gynecologic Oncology. 2013 Oct;131(1):264. doi: 10.1016/j.ygyno.2013.07.046.
-
- Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.
- Heemskerk-Gerritsen BA, Menke-Pluijmers MB, Jager A, Tilanus-Linthorst MM, Koppert LB, Obdeijn IM, van Deurzen CH, Collée JM, Seynaeve C, Hooning MJ.
- Ann Oncol. 2013 Aug;24(8):2029-35. doi: 10.1093/annonc/mdt134. Epub 2013 Apr 10.
- PMID: 23576707
- PubMed abstract
- Source abstract
-
- Genetic Counseling, Cancer Screening, Breast Cancer Characteristics, and General Health among a Diverse Population of BRCA Genetic Testers.
- Beattie MS, Copeland K, Fehniger J, Cheung E, Joseph G, Lee R, Luce J.
- J Health Care Poor Underserved. [2013 Aug;]24(3):1150-66. doi: 10.1353/hpu.2013.0151.
- PMID: 23974388
- PubMed abstract
- Source abstract
-
- Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.
- Mannis GN, Fehniger JE, Creasman JS, Jacoby VL, Beattie MS.
- JAMA Intern Med. 2013 Jan 28;173(2):96-103. doi: 10.1001/2013.jamainternmed.962.
- PMID: 23247828
- PubMed abstract
Comment:
Role of genetic testing for screening and prevention for ovarian cancer: comment on "Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing".
- PMID: 23247884
- PubMed abstract
- Source abstract
-
- Role of genetic testing for screening and prevention for ovarian cancer: comment on "Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing".
- Grann V, Ashby-Thompson M.
- JAMA Intern Med. 2013 Jan 28;173(2):103-4. doi: 10.1001/jamainternmed.2013.2729.
- PMID: 23247884
- PubMed abstract
- Comment
- Free Full Text
Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.
- PMID: 23247828
- PubMed abstract
- Free Full Text
-
- Breast MRI Use Uncommon among U.S. Women.
- Miller JW, Sabatino SA, Thompson TD, Breen N, White MC, Ryerson AB, Taplin S, Ballard-Barbash R.
- Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):159-66. doi: 10.1158/1055-9965.EPI-12-0967. Epub 2012 Nov 15.
- PMID: 23155135
- PubMed abstract
- Source abstract
-
- Compliance with screening recommendations according to breast cancer risk levels in Izmir, Turkey.
- Acikgoz A, Ergor G.
- Asian Pac J Cancer Prev. 2013;14(3):1737-42.
- PMID: 23679266
- PubMed abstract
- Source abstract
-
- BRCA1/2 testing and cancer risk management in underserved women at a public hospital.
- Hamann HA, Robinson LD, Moldrem AW, Golden EP, Mook JA, Pechero Bishop W, Sugg Skinner C, Euhus DM.
- Commun Oncol 2012 Dec;9(12):369-376.
-
- Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
- Metcalfe KA, Mian N, Enmore M, Poll A, Llacuachaqui M, Nanda S, Sun P, Hughes KS, Narod SA.
- Breast Cancer Res Treat. 2012 Jun;133(2):735-40. doi: 10.1007/s10549-011-1941-0. Epub 2012 Jan 13.
- PMID: 22240989
- PubMed abstract
- Source abstract
-
- Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
- Schwartz MD, Isaacs C, Graves KD, Poggi E, Peshkin BN, Gell C, Finch C, Kelly S, Taylor KL, Perley L.
- Cancer. 2012 Jan 15;118(2):510-7. doi: 10.1002/cncr.26294. Epub 2011 Jun 29.
- PMID: 21717445
- PubMed abstract
- Source abstract
-
- Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic.
- Brinton JT, Barke LD, Freivogel ME, Jackson S, O'Donnell CI, Glueck DH.
- Acad Radiol. 2012 Jan;19(1):95-9. doi: 10.1016/j.acra.2011.09.003. Epub 2011 Nov 3.
- PMID: 22054804
- PubMed abstract
- Source abstract